ALHC RSI Chart
Last 7 days
6.2%
Last 30 days
46.5%
Last 90 days
9.2%
Trailing 12 Months
9.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 2.0B | 0 | 0 | 0 |
2023 | 1.5B | 1.6B | 1.7B | 1.8B |
2022 | 1.2B | 1.3B | 1.4B | 1.4B |
2021 | 1.0B | 1.1B | 1.1B | 1.2B |
2020 | 807.5M | 858.1M | 908.7M | 959.2M |
2019 | 0 | 0 | 0 | 757.0M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 28, 2024 | scavo robert l. | sold | -8,813 | 4.84 | -1,821 | chief information officer |
Mar 28, 2024 | maroney dawn christine | sold | -49,130 | 4.84 | -10,151 | president, markets |
Mar 28, 2024 | freeman robert thomas | sold | -20,807 | 4.84 | -4,299 | chief financial officer |
Mar 28, 2024 | kardes hakan | sold | -21,116 | 4.84 | -4,363 | chief experience officer |
Mar 20, 2024 | maroney dawn christine | sold | -64,007 | 4.83 | -13,252 | president, markets |
Mar 19, 2024 | kim hyong | sold | -28,163 | 5.0508 | -5,576 | chief medical officer |
Mar 19, 2024 | maroney dawn christine | sold | -80,110 | 5.0508 | -15,861 | president, markets |
Mar 19, 2024 | joyce christopher j | sold | -126,573 | 5.0508 | -25,060 | chief legal and admin. officer |
Mar 19, 2024 | scavo robert l. | sold | -15,546 | 5.0508 | -3,078 | chief information officer |
Mar 19, 2024 | freeman robert thomas | sold | -144,059 | 5.0508 | -28,522 | chief financial officer |
Which funds bought or sold ALHC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -3.98 | -408,959 | 506,267 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -35.75 | -590,018 | 346,733 | -% |
May 16, 2024 | COMERICA BANK | sold off | -100 | -1,584 | - | -% |
May 15, 2024 | PDT Partners, LLC | reduced | -77.45 | -713,910 | 106,580 | 0.01% |
May 15, 2024 | Cresset Asset Management, LLC | added | 0.01 | -1,079,340 | 1,467,010 | 0.01% |
May 15, 2024 | ALGERT GLOBAL LLC | unchanged | - | -222,000 | 301,000 | 0.01% |
May 15, 2024 | Concorde Asset Management, LLC | added | 146 | 82,977 | 280,835 | 0.19% |
May 15, 2024 | Brevan Howard Capital Management LP | new | - | 94,736 | 94,736 | -% |
May 15, 2024 | ADAGE CAPITAL PARTNERS GP, L.L.C. | new | - | 1,686,400 | 1,686,400 | -% |
May 15, 2024 | PRELUDE CAPITAL MANAGEMENT, LLC | new | - | 54,064 | 54,064 | -% |
Unveiling Alignment Healthcare, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Alignment Healthcare, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 482.9B | 379.5B | 31.44 | 1.27 | ||||
CI | 96.2B | 206.0B | 24.97 | 0.47 | ||||
HCA | 84.6B | 66.7B | 15.46 | 1.27 | ||||
CVS | 72.4B | 360.9B | 9.89 | 0.2 | ||||
CNC | 41.7B | 155.5B | 15.24 | 0.27 | ||||
DVA | 12.3B | 12.3B | 15.03 | 0.99 | ||||
UHS | 11.9B | 14.7B | 14.63 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 8.5B | 2.3B | 30.15 | 3.73 | ||||
ACHC | 6.2B | 3.0B | -545.12 | 2.06 | ||||
AMEH | 2.3B | 1.5B | 36.62 | 1.57 | ||||
AMN | 2.2B | 3.5B | 15.49 | 0.64 | ||||
SMALL-CAP | ||||||||
ADUS | 1.8B | 1.1B | 27.59 | 1.67 | ||||
BKD | 1.3B | 3.0B | -7.66 | 0.44 | ||||
BEAT | 54.5M | - | -3.61 | - | ||||
AMS | 22.0M | 21.6M | 39.79 | 1.02 |
Alignment Healthcare, Inc. News
Income Statement (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Revenue | 35.1% | 628,601,000 | 465,387,000 | 456,709,000 | 462,379,000 | 439,155,000 | 361,811,000 | 360,348,000 | 366,474,000 | 345,526,000 | 298,274,000 | 293,466,000 | 308,951,000 | 267,082,000 | 242,409,000 | 247,867,000 | 244,313,000 | 224,633,000 | - |
Operating Expenses | 32.0% | 669,707,000 | 507,300,000 | 486,465,000 | 486,038,000 | 471,644,000 | 413,917,000 | 393,758,000 | 373,122,000 | 382,001,000 | 341,740,000 | 334,916,000 | 349,443,000 | 319,746,000 | 270,204,000 | 232,807,000 | 231,726,000 | 229,748,000 | - |
S&GA Expenses | 8.1% | 90,512,000 | 83,737,000 | 83,089,000 | 70,199,000 | 70,408,000 | 83,228,000 | 76,452,000 | 61,673,000 | 74,293,000 | 78,081,000 | 76,846,000 | 71,150,000 | 64,914,000 | 51,119,000 | 38,794,000 | 33,698,000 | 32,787,000 | - |
EBITDA Margin | 2.7% | -0.06 | -0.06 | -0.07 | -0.08 | -0.07 | -0.08 | -0.08 | -0.09 | -0.12 | -0.14 | -0.13 | -0.08 | - | - | - | - | - | - |
Interest Expenses | -1.0% | 5,427,000 | 5,484,000 | 5,466,000 | 5,262,000 | 5,019,000 | 4,793,000 | 4,605,000 | 4,490,000 | 4,401,000 | 4,452,000 | 4,414,000 | 4,329,000 | 4,248,000 | 4,308,000 | 4,271,000 | 4,192,000 | 4,160,000 | - |
Income Taxes | 100.0% | - | -24,000 | - | 1,000 | 1,000 | 172,000 | 167,000 | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 1.4% | -46,575,000 | -47,255,000 | -35,077,000 | -28,493,000 | -37,370,000 | -56,823,000 | -40,080,000 | -11,580,000 | -40,817,000 | -47,834,000 | -45,816,000 | -44,762,000 | -56,874,000 | -32,065,000 | 10,846,000 | 8,365,000 | -10,072,000 | - |
EBT Margin | 3.8% | -0.08 | -0.08 | -0.09 | -0.10 | -0.10 | -0.10 | -0.10 | -0.11 | -0.14 | -0.17 | -0.16 | -0.12 | - | - | - | - | - | - |
Net Income | 1.5% | -46,521,000 | -47,209,000 | -35,047,000 | -28,477,000 | -37,284,000 | -56,903,000 | -40,247,000 | -11,580,000 | -40,817,000 | -47,834,000 | -45,816,000 | -44,762,000 | -56,874,000 | -32,065,000 | 10,846,000 | 8,365,000 | -10,072,000 | - |
Net Income Margin | 3.8% | -0.08 | -0.08 | -0.09 | -0.10 | -0.10 | -0.10 | -0.10 | -0.11 | -0.14 | -0.17 | -0.16 | -0.12 | - | - | - | - | - | - |
Free Cashflow | -Infinity% | -17,359,000 | - | -1,293,000 | 29,892,000 | 77,825,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2019Q4 |
Assets | 7.0% | 633 | 592 | 771 | 784 | 762 | 634 | 778 | 667 | 647 | 631 | 657 | 670 | 679 | 339 | 193 |
Current Assets | 7.7% | 521 | 484 | 667 | 684 | 671 | 545 | 692 | 586 | 566 | 553 | 577 | 593 | 605 | 265 | 127 |
Cash Equivalents | 18.8% | 241 | 203 | 392 | 395 | 384 | 410 | 567 | 453 | 449 | 467 | 500 | 495 | 528 | 208 | 86.00 |
Net PPE | 10.2% | 57.00 | 52.00 | 47.00 | 43.00 | 40.00 | 37.00 | 36.00 | 33.00 | 32.00 | 30.00 | 32.00 | 30.00 | 28.00 | 27.00 | 27.00 |
Goodwill | 0% | 35.00 | 35.00 | - | - | - | 35.00 | - | - | - | - | - | - | - | - | - |
Liabilities | 15.5% | 501 | 434 | 581 | 572 | 538 | 395 | 505 | 373 | 353 | 325 | 332 | 330 | 325 | 308 | 272 |
Current Liabilities | 25.7% | 331 | 263 | 410 | 402 | 374 | 230 | 340 | 214 | 195 | 167 | 175 | 174 | 170 | 153 | 130 |
Long Term Debt | 0.1% | 162 | 162 | 162 | 161 | 161 | 161 | 161 | 154 | 152 | 151 | 149 | 147 | 146 | 144 | 138 |
LT Debt, Non Current | -100.0% | - | 162 | 162 | 161 | 161 | 161 | 161 | 154 | 152 | 151 | 149 | 147 | 146 | 144 | 138 |
Shareholder's Equity | -15.9% | 132 | 157 | 189 | 211 | 224 | 238 | 272 | 294 | 293 | 306 | 325 | 340 | 354 | 31.00 | 79.00 |
Retained Earnings | -5.3% | -926 | -880 | -833 | -798 | -769 | -732 | -675 | -635 | -623 | -582 | -527 | -481 | -436 | -379 | -78.71 |
Additional Paid-In Capital | 2.0% | 1,058 | 1,037 | 1,021 | 1,008 | 992 | 970 | 947 | 929 | 917 | 889 | 852 | 821 | 791 | 410 | - |
Shares Outstanding | 1.2% | 191 | 189 | 189 | 189 | 188 | 187 | 187 | 187 | 187 | 187 | 187 | 187 | - | - | - |
Minority Interest | -3.5% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | - | - | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - |
Float | - | - | - | - | 675 | - | - | - | 950 | - | - | - | 1,321 | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Cashflow From Operations | 96.7% | -6,238 | -187,466 | 5,992 | 37,177 | 85,110 | -149,263 | 105,120 | 10,354 | -11,638 | -30,134 | 12,914 | -23,449 | -38,107 | -10,146 | 26,039 | 13,487 | -21,819 | - |
Share Based Compensation | 33.2% | 20,854 | 15,652 | 13,569 | 15,636 | 21,978 | 22,885 | 18,687 | 12,099 | 28,047 | 28,814 | 30,511 | 30,887 | 31,787 | 1,144 | 304 | 350 | 326 | - |
Cashflow From Investing | 4295.0% | 42,705 | -1,018 | -9,607 | -26,210 | -110,428 | -8,107 | -8,128 | -5,855 | -6,127 | -2,951 | -6,997 | -6,421 | -4,446 | -4,725 | -4,258 | -3,640 | -3,735 | - |
Cashflow From Financing | -844.4% | -335 | 45.00 | - | 30.00 | 30.00 | -527 | 17,220 | -100 | - | - | - | -3,529 | 363,659 | -144 | -338 | -878 | 131,484 | - |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,474 | 144 | 338 | 507 | 516 | - |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues: | ||
Earned premiums | $ 621,556 | $ 434,812 |
Other | 7,045 | 4,343 |
Total revenues | 628,601 | 439,155 |
Expenses: | ||
Medical expenses | 573,218 | 396,315 |
Selling, general, and administrative expenses | 90,512 | 70,408 |
Depreciation and amortization | 5,977 | 4,921 |
Total expenses | 669,707 | 471,644 |
Loss from operations | (41,106) | (32,489) |
Other expenses: | ||
Interest expense | 5,427 | 5,019 |
Other expenses (income) | 42 | (138) |
Total other expenses | 5,469 | 4,881 |
Loss before income taxes | (46,575) | (37,370) |
Provision for income taxes | 0 | 1 |
Net loss | (46,575) | (37,371) |
Less: Net loss attributable to noncontrolling interest | 54 | 87 |
Net loss attributable to Alignment Healthcare, Inc. | $ (46,521) | $ (37,284) |
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic (in shares) | 189,005,394 | 183,113,945 |
Total weighted-average common shares outstanding, net of restricted shares of common stock - diluted (in shares) | 189,005,394 | 183,113,945 |
Net loss per share - basic (in dollars per share) | $ (0.25) | $ (0.20) |
Net loss per share - diluted (in dollars per share) | $ (0.25) | $ (0.20) |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 238,903 | $ 202,904 |
Accounts receivable (less allowance for credit losses of $0 at March 31, 2024 and December 31, 2023) | 165,071 | 119,749 |
Investments - current | 62,809 | 115,914 |
Prepaid expenses and other current assets | 53,856 | 44,970 |
Total current assets | 520,639 | 483,537 |
Property and equipment, net | 57,211 | 51,901 |
Right of use asset, net | 8,549 | 9,959 |
Goodwill | 34,826 | 34,826 |
Intangible Assets, net | 5,224 | 5,252 |
Other assets | 6,781 | 6,405 |
Total assets | 633,230 | 591,880 |
Current Liabilities: | ||
Medical expenses payable | 276,464 | 205,399 |
Accounts payable and accrued expenses | 22,671 | 23,511 |
Accrued compensation | 31,607 | 34,112 |
Total current liabilities | 330,742 | 263,022 |
Long-term debt, net of debt issuance costs | 162,030 | 161,813 |
Long-term portion of lease liabilities | 8,441 | 8,974 |
Total liabilities | 501,213 | 433,809 |
Commitments and Contingencies (Note 12) | ||
Stockholders' Equity: | ||
Preferred stock, $.001 par value; $100,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $.001 par value; $1,000,000,000 shares authorized as of March 31, 2024 and December 31, 2023; $191,156,569 and $188,951,643 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 191 | 189 |
Additional paid-in capital | 1,057,519 | 1,037,015 |
Accumulated deficit | (926,779) | (880,258) |
Total Alignment Healthcare, Inc. stockholders' equity | 130,931 | 156,946 |
Noncontrolling interest | 1,086 | 1,125 |
Total stockholders' equity | 132,017 | 158,071 |
Total liabilities and stockholders' equity | $ 633,230 | $ 591,880 |